Nuvectis Pharma, Inc.
$18.60
-0.33 (-1.74%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -13.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -30.5%
Own NVCT?
See how NVCT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.